PhaseV raises $15 Million in funding

Clinical Trial Platform Uncovers Hidden Signals and Optimizes Next Steps for More Adaptive, Successful, and Efficient Clinical Trials PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in funding, led by Viola Ventures and Exor Ventures, including participation from LionBird...

The post PhaseV raises $15 Million in funding first appeared on AI-TechPark.

analysis clinical clinical trial clinical trials design funding hidden machine machine learning next platform raises technology